Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...

San Francisco-based Trace Neuroscience has launched with $101 million in series A funding to develop ALS therapies focused on ...

Among the various forms of MND, amyotrophic lateral sclerosis (ALS) is most prevalent in the UK, impacting around 5,000 ...

Her husband, Scott Sessa, said that her death, in a hospital, was caused by complications of amyotrophic lateral sclerosis ...

Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...

Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...